학술논문
Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma
Document Type
Article
Author
Source
In: International Journal of Clinical Oncology . (International Journal of Clinical Oncology, March 2023, 28(3):416-426)
Subject
Language
English
ISSN
14377772
13419625
13419625